Pub. Date : 2002 Nov
PMID : 12399758
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | CONCLUSION: This single-center study supports the safety and efficacy of bexarotene as both a monotherapy and a combination therapy for CTCL. | Bexarotene | TSPY like 2 | Homo sapiens |
| 2 | When bexarotene is combined with other active CTCL therapies, higher RRs were achieved in patients with advanced disease, without unacceptable side effects. | Bexarotene | TSPY like 2 | Homo sapiens |